These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6333863)

  • 21. Clonal restriction of complement-fixing antineural antibodies in the Guillain-Barré syndrome.
    Ryberg B
    Ann N Y Acad Sci; 1988; 540():384-6. PubMed ID: 3207264
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibodies to peripheral nerve tissue in sera from patients with acute Guillain-Barré syndrome demonstrated by a mixed haemagglutination technique.
    Vedeler CA; Nyland H; Matre R
    J Neuroimmunol; 1982 Jun; 2(3-4):209-14. PubMed ID: 7085862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tick-borne lymphocytic meningoradiculitis in Ireland: Bannwarth's syndrome/Lyme disease.
    Carmody E; Hutchinson M
    Ir Med J; 1987 May; 80(5):154. PubMed ID: 3597040
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of Statin Use on the Clinical Manifestations, Laboratory Test Results and Outcome of Lyme Neuroborreliosis.
    Ogrinc K; Kastrin A; Lotrič-Furlan S; Bogovič P; Rojko T; Cerar-Kišek T; Ružić-Sabljić E; Wormser GP; Strle F
    J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32948002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bannwarth's syndrome--a spirochetal cause of meningoradiculitis].
    Marttila R; Panelius M
    Duodecim; 1985; 101(12):1191-7. PubMed ID: 4017909
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies.
    Chiba A; Kusunoki S; Obata H; Machinami R; Kanazawa I
    Neurology; 1993 Oct; 43(10):1911-7. PubMed ID: 8413947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
    Odaka M; Yuki N; Yoshino H; Kasama T; Handa S; Irie F; Hirabayashi Y; Suzuki A; Hirata K
    Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum antibodies to gangliosides in Guillain-Barré syndrome.
    Ilyas AA; Willison HJ; Quarles RH; Jungalwala FB; Cornblath DR; Trapp BD; Griffin DE; Griffin JW; McKhann GM
    Ann Neurol; 1988 May; 23(5):440-7. PubMed ID: 3133978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
    Khalili-Shirazi A; Gregson N; Gray I; Rees J; Winer J; Hughes R
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):376-9. PubMed ID: 10084538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.
    Koski CL; Humphrey R; Shin ML
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):905-9. PubMed ID: 3856240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome.
    Jacobs BC; Hazenberg MP; van Doorn PA; Endtz HP; van der Meché FG
    J Infect Dis; 1997 Mar; 175(3):729-33. PubMed ID: 9041356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Argyll Robertson pupils in lymphocytic meningoradiculitis (Bannwarth's syndrome).
    Koudstaal PJ; Vermeulen M; Wokke JH
    J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):363-5. PubMed ID: 3559622
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
    Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
    Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demyelination in vivo by Guillain-Barré syndrome and other human serum.
    Brown MJ; Rosen JL; Lisak RP
    Muscle Nerve; 1987; 10(3):263-71. PubMed ID: 3561445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study.
    Buchwald B; Toyka KV; Zielasek J; Weishaupt A; Schweiger S; Dudel J
    Ann Neurol; 1998 Dec; 44(6):913-22. PubMed ID: 9851436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA.
    Irie S; Saito T; Kanazawa N; Ogino M; Ogino Y; Sakai F
    Intern Med; 2003 Jun; 42(6):490-5. PubMed ID: 12857046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome.
    Koski CL; Gratz E; Sutherland J; Mayer RF
    Ann Neurol; 1986 Jun; 19(6):573-7. PubMed ID: 3729311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of axonal Guillain-Barré syndrome: hypothesis.
    Yuki N
    Muscle Nerve; 1994 Jun; 17(6):680-2. PubMed ID: 8196713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lymphocytic meningoradiculitis--Bannwarth's syndrome].
    Lademann A
    Ugeskr Laeger; 1984 Mar; 146(12):874-6. PubMed ID: 6719585
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lymphocytic meningoradiculitis--Bannwarth's syndrome].
    Hansen K; Wulff CH; Strange P; Trojaborg W
    Ugeskr Laeger; 1984 Mar; 146(12):870-4. PubMed ID: 6719584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.